| # | Side effect | Count |
|---|---|---|
| 0 | MALIGNANT NEOPLASM PROGRESSION | 63 |
| 1 | PRODUCT USE IN UNAPPROVED INDICATION | 40 |
| 2 | PANCREATIC NEUROENDOCRINE TUMOUR | 37 |
| 3 | DRUG INEFFECTIVE | 35 |
| 4 | HYPOGLYCAEMIA | 35 |
| 5 | FATIGUE | 34 |
| 6 | NAUSEA | 29 |
| 7 | OFF LABEL USE | 28 |
| 8 | DISEASE PROGRESSION | 24 |
| 9 | DECREASED APPETITE | 23 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | HEPATIC NEOPLASM MALIGNANT NON-RESECTABLE | 1 | 0.0588 |
| 1 | PANCREATIC NEUROENDOCRINE TUMOUR | 37 | 0.0577 |
| 2 | CLONAL EVOLUTION | 4 | 0.0385 |
| 3 | PORTAL VEIN EMBOLISM | 1 | 0.0385 |
| 4 | BLOOD GLUCAGON INCREASED | 1 | 0.0217 |
| 5 | SMALL INTESTINE NEUROENDOCRINE TUMOUR | 1 | 0.0182 |
| 6 | RETROPERITONEAL CANCER | 1 | 0.0125 |
| 7 | BLOOD CHROMOGRANIN A INCREASED | 5 | 0.0109 |
| 8 | TUMOUR NECROSIS | 10 | 0.0095 |
| 9 | GASTRIC ANTRAL VASCULAR ECTASIA | 5 | 0.0095 |